tetraiodothyroacetic acid has been researched along with Hepatocellular Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlsen, J; Göke, B; Heuer, H; Müller, AM; Nelson, PJ; Rühland, S; Salb, N; Schmohl, KA; Schwenk, N; Spitzweg, C; Wechselberger, A | 1 |
1 other study(ies) available for tetraiodothyroacetic acid and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Cell Movement; Culture Media, Conditioned; Heterografts; Humans; Hyperthyroidism; Hypothyroidism; Integrin alphaVbeta3; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mesenchymal Stem Cells; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Specific Pathogen-Free Organisms; Spheroids, Cellular; Stromal Cells; Thyroxine; Triiodothyronine; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2015 |